Patents by Inventor Latika Singh

Latika Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuroprotective compositions and methods of using the same
    Patent number: 11974988
    Abstract: This invention is directed to neuroprotective compositions and methods of using the same to treat neurodegenerative diseases.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: May 7, 2024
    Assignees: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jeffrey Erickson, Heike Wulff, Heesung Shim, Vikrant Singh, Latika Singh
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20220033497
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: July 16, 2021
    Publication date: February 3, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20220025043
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 27, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20220025042
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 27, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20220010010
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 13, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20220010011
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 13, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
    Patent number: 11111297
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: September 7, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael A. Meehl, Philip E. Brandish, Laurence Fayadat-Dilman, Veronica Juan, Carl Mieczkowski, Latika Singh
  • NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20210205275
    Abstract: This invention is directed to neuroprotective compositions and methods of using the same to treat neurodegenerative diseases.
    Type: Application
    Filed: November 16, 2020
    Publication date: July 8, 2021
    Inventors: Jeffrey ERICKSON, Heike WULFF, Heesung SHIM, Vikrant SINGH, Latika SINGH
  • ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
    Publication number: 20190153093
    Abstract: Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
    Type: Application
    Filed: November 15, 2018
    Publication date: May 23, 2019
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: MICHAEL A. MEEHL, PHILIP E. BRANDISH, LAURENCE FAYADAT-DILMAN, VERONICA JUAN, CARL MIECZKOWSKI, LATIKA SINGH
  • Synthetic heparin pentasaccharides
    Patent number: 9243018
    Abstract: Preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: January 26, 2016
    Assignee: DR. REDDY'S LABORATORIES, SA
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • SYNTHETIC HEPARIN PENTASACCHARIDES
    Publication number: 20150005485
    Abstract: Preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides useful for the preparation of synthetic heparinoids.
    Type: Application
    Filed: January 29, 2014
    Publication date: January 1, 2015
    Applicant: ALCHEMIA LIMITED
    Inventors: Joachim SEIFERT, Latika SINGH, Tracie E. RAMSDALE, Michael L. WEST, Nicholas B. DRINNAN
  • Synthetic heparin trisaccharides
    Patent number: 8686131
    Abstract: Preparation and use of synthetic trisaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: April 1, 2014
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Synthetic heparin disaccharides
    Patent number: 8404833
    Abstract: Preparation and use of synthetic disaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: March 26, 2013
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • SYNTHETIC HEPARIN DISACCHARIDES
    Publication number: 20120220759
    Abstract: Preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
    Type: Application
    Filed: December 14, 2011
    Publication date: August 30, 2012
    Applicant: Alchemia Limited
    Inventors: Joachim SEIFERT, Latika SINGH, Tracie Elizabeth RAMSDALE, Michael Leo WEST, Nicholas Barry DRINNAN
  • SYNTHETIC HEPARIN TRISACCHARIDES
    Publication number: 20120208993
    Abstract: Preparation and use of synthetic trisaccharides useful for the preparation of synthetic heparinoids.
    Type: Application
    Filed: December 14, 2011
    Publication date: August 16, 2012
    Applicant: Alchemia Limited
    Inventors: Joachim SEIFERT, Latika SINGH, Tracie Elizabeth RAMSDALE, Michael Leo WEST, Nicholas Barry DRINNAN
  • Synthetic heparin monosaccharides
    Patent number: 8114970
    Abstract: Preparation of synthetic monosaccharides, for use in the preparation of synthetic heparinoids.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: February 14, 2012
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • SYNTHETIC HEPARIN PENTASACCHARIDES
    Publication number: 20090187013
    Abstract: Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
    Type: Application
    Filed: January 15, 2009
    Publication date: July 23, 2009
    Applicant: Alchemia Limited
    Inventors: Joachim SEIFERT, Latika Singh, Tracie Elizabeth Ramsdale, Michael Leo West, Nicholas Barry Drinnan
  • Synthetic heparin pentasaccharides
    Patent number: 7541445
    Abstract: Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: June 2, 2009
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Synthetic heparin pentasaccharides
    Publication number: 20050080042
    Abstract: Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
    Type: Application
    Filed: September 6, 2002
    Publication date: April 14, 2005
    Inventors: Joachim Seifert, Latika Singh, Tracie Ramsdale, Michael West, Nicholas Drinnan